Scientists at Rigshopitalet, Herlev Hospital and the University of Copenhagen have now identified a new biomarker, called apolipoprotein E, measurable in a simple blood test, which will help predict the possibility of developing dementia. During the study, researchers showed that a low level of this biomarker in our blood, increases the risk of developing dementia in the future. They hope that this new blood test could soon be applicable in clinical practice.
Assistant clinical and research professor Ruth Frikke-Schmidt said, "The blood test would help provide a more precise risk evaluation of a citizen's risk of developing dementia later in life. The blood test would enable an earlier and more focused prevention effort, thus prolonging the onset of the illness and raising the individual's quality of life."
The study is published in the internationally acclaimed journal, the Annals of Neurology.